Prospective studies on the expression of HNRNPA2B1 and its role in immune infiltration of human cancers are needed next, as well as the successful development and testing of novel antitumor immunotherapeutic agents targeting HNRNPA2B1. Here, HNRNPA2B1 is linked to cancer.